Zyrolbine 50mg (Vinorelbine Vials) 50mg/5ml

Zyrolbine 50mg is a vinorelbine injection used for cancer treatment. This 50mg/5ml vial supports chemotherapy regimens with precise dosing. Store at 2-8°C to maintain potency. Ideal for oncology protocols requiring vinorelbine therapy.

Strength

50mg/5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Zuvius Life Sciences Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zyrolbine 50mg (vinorelbine) is prescribed to treat various cancers, including non-small cell lung cancer and breast cancer. It works by interfering with cancer cell growth during chemotherapy cycles. Patients often ask what is Zyrolbine 50mg used for in combination therapies. This medication may be used when other treatments are ineffective or as part of first-line regimens.

Side Effects

During treatment with Zyrolbine 50mg, patients may experience effects like fatigue or mild nausea. Some notice temporary changes in blood cell counts, which are monitored regularly. Hair thinning is another common observation during vinorelbine therapy. These effects vary by individual and treatment stage.

Precautions & Warnings

Handle Zyrolbine 50mg vials with care to avoid skin contact or accidental exposure. Use protective gloves and dispose of materials properly per medical waste guidelines. Keep vials refrigerated between 2-8°C and protect from light. Always follow healthcare provider instructions for safe administration.

Avoid Interactions

Zyrolbine 50mg may interact with medications that affect liver enzymes, such as certain antifungals or antibiotics. Alcohol consumption should be discussed with a doctor due to potential increased side effects. Live vaccines are generally avoided during vinorelbine therapy. Always disclose all current medications to your healthcare provider.

Frequently Asked Questions

Zyrolbine 50mg is used to treat certain cancers like non-small cell lung cancer and breast cancer as part of chemotherapy.

Store Zyrolbine 50mg vials refrigerated between 2-8°C and protect from light until use.

Hair thinning or loss is a possible effect during vinorelbine therapy, though not experienced by everyone.

Pregnancy use requires medical consultation as vinorelbine may harm an unborn baby.

Common effects include fatigue, nausea, and changes in blood cell counts during treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.